Overview

Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this summary is to evaluate the efficacy and safety of R89674 0.025% ophthalmic solution compared with placebo or an active control in subjects with seasonal allergic conjunctivitis
Phase:
Phase 3
Details
Lead Sponsor:
Vistakon Pharmaceuticals
Treatments:
Ophthalmic Solutions
Pharmaceutical Solutions